{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:02:05Z","timestamp":1789524125273,"version":"build-2803163510"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13875-6","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T16:46:01Z","timestamp":1782578761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lessons in the Wake of a Lassa fever case in the Midwest U.S: epidemiology, management and preparedness gaps"],"prefix":"10.1186","volume":"26","author":[{"given":"Sanchez-Lopez","family":"Sebastian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cerino-Pe\u00f1aloza","family":"Maria Susana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padilla-Zambrano","family":"Huber Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brust","family":"Karen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"issue":"14","key":"13875_CR1","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1001\/jama.2020.17395","volume":"324","author":"JB Nuzzo","year":"2020","unstructured":"Nuzzo JB, Bell JA, Cameron EE. Suboptimal US Response to COVID-19 Despite Robust Capabilities and Resources. JAMA. 2020;324(14):1391.","journal-title":"JAMA"},{"issue":"7","key":"13875_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3201\/eid2907.221769","volume":"29","author":"J Broertjes","year":"2023","unstructured":"Broertjes J, Franz E, Friesema IHM, Jansen HJ, Reubsaet FAG, Rutjes SA, et al. Epidemiology of Pathogens Listed as Potential Bioterrorism Agents, the Netherlands, 2009\u20132019. Emerg Infect Dis. 2023;29(7):1\u20139.","journal-title":"Emerg Infect Dis"},{"key":"13875_CR3","unstructured":"World Health Organization. Lassa fever. World Health Organization. 2024 [cited 2025 Dec 8]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/lassa-fever"},{"key":"13875_CR4","unstructured":"Africa centers for disease control and prevention. Lassa fever. Africa centers for disease control and prevention. 2025 [cited 2025 Dec 8]. Available from: https:\/\/africacdc.org\/disease\/lassa-fever\/"},{"key":"13875_CR5","unstructured":"Center for Food Security and Public Health. The CDC category listing of potential bioterrorism agents. Center for Food Security and Public Health. 2005 [cited 2025 Dec 8]. Available from: https:\/\/www.cfsph.iastate.edu\/pdf\/cdc-category-listing-of-potential-bioterrorism-agents"},{"issue":"12","key":"13875_CR6","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1038\/s41591-024-03232-y","volume":"30","author":"DRM Smith","year":"2024","unstructured":"Smith DRM, Turner J, Fahr P, Attfield LA, Bessell PR, Donnelly CA, et al. Health and economic impacts of Lassa vaccination campaigns in West Africa. Nat Med. 2024;30(12):3568\u201377.","journal-title":"Nat Med"},{"issue":"12","key":"13875_CR7","doi-asserted-by":"publisher","first-page":"e1962","DOI":"10.1016\/S2214-109X(24)00379-6","volume":"12","author":"P Doohan","year":"2024","unstructured":"Doohan P, Jorgensen D, Naidoo TM, McCain K, Hicks JT, McCabe R, et al. Lassa fever outbreaks, mathematical models, and disease parameters: a systematic review and meta-analysis. Lancet Glob Health. 2024;12(12):e1962\u201372.","journal-title":"Lancet Glob Health"},{"issue":"11","key":"13875_CR8","doi-asserted-by":"publisher","first-page":"e696","DOI":"10.1016\/S1473-3099(24)00229-9","volume":"24","author":"KA Moore","year":"2024","unstructured":"Moore KA, Ostrowsky JT, Mehr AJ, Johnson RA, Ulrich AK, Moua NM, et al. Lassa fever research priorities: towards effective medical countermeasures by the end of the decade. Lancet Infect Dis. 2024;24(11):e696\u2013706.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"13875_CR9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/tropicalmed9080178","volume":"9","author":"ME Besson","year":"2024","unstructured":"Besson ME, P\u00e9pin M, Metral PA. Lassa Fever: Critical Review and Prospects for Control. Trop Med Infect Dis. 2024;9(8):178.","journal-title":"Trop Med Infect Dis"},{"issue":"4","key":"13875_CR10","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/v17040504","volume":"17","author":"NA Davis","year":"2025","unstructured":"Davis NA, Kenyon MA, Ghersi BM, Sparks JLD, Gass JD. Assessing the Environmental Drivers of Lassa Fever in West Africa: A Systematic Review. Viruses. 2025;17(4):504.","journal-title":"Viruses"},{"issue":"1","key":"13875_CR11","doi-asserted-by":"publisher","first-page":"27669","DOI":"10.1038\/s41598-024-78726-3","volume":"14","author":"AI Al-Mustapha","year":"2024","unstructured":"Al-Mustapha AI, Adesiyan IM, Orum TG, Ogundijo OA, Lawal AN, Nzedibe OE, et al. Lassa fever in Nigeria: epidemiology and risk perception. Sci Rep. 2024;14(1):27669.","journal-title":"Sci Rep"},{"key":"13875_CR12","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1017\/S095026882400164X","volume":"152","author":"DJ Sama","year":"2024","unstructured":"Sama DJ, Haider N, Guitian J, Osman AY, Ntoumi F, Zumla A, et al. Identifying risk factors for clinical Lassa fever in Sierra Leone, 2019\u20132021. Epidemiol Infect. 2024;152:e177.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"13875_CR13","doi-asserted-by":"publisher","first-page":"2294859","DOI":"10.1080\/22221751.2023.2294859","volume":"13","author":"AN Happi","year":"2024","unstructured":"Happi AN, Ogunsanya OA, Ayinla AO, Sijuwola AE, Saibu FM, Akano K, et al. Lassa virus in novel hosts: insights into the epidemiology of lassa virus infections in southern Nigeria. Emerg Microbes Infect. 2024;13(1):2294859.","journal-title":"Emerg Microbes Infect"},{"issue":"3","key":"13875_CR14","first-page":"279","volume":"38","author":"YL Feng","year":"2025","unstructured":"Feng YL, Li W, Jiang MF, Zhong HR, Wu W, Tian LB, et al. Laboratory Diagnosis and Molecular Epidemiological Characterization of the First Imported Case of Lassa Fever in China. Biomed Environ Sci. 2025;38(3):279\u201389.","journal-title":"Biomed Environ Sci"},{"issue":"11","key":"13875_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.15585\/mmwr.mm7411a3","volume":"74","author":"DL Von Stein","year":"2025","unstructured":"Von Stein DL, Barger A, Hennenfent A, Ramaekers R, Mandi A, Teno K, et al. Notes from the Field: Response to a Case of Travel-Associated Lassa Fever \u2014 Iowa, October\u2013November 2024. MMWR Morb Mortal Wkly Rep. 2025;74(11):194\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"13875_CR16","doi-asserted-by":"publisher","first-page":"670","DOI":"10.4269\/ajtmh.1970.19.670","volume":"19","author":"JD Frame","year":"1970","unstructured":"Frame JD, Baldwin JM, Gocke DJ, Troup JM. Lassa Fever, a New Virus Disease of Man from West Africa. Am J Trop Med Hyg. 1970;19(4):670\u20136.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"13875_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3201\/eid2502.180836","volume":"25","author":"A Kofman","year":"2019","unstructured":"Kofman A, Choi MJ, Rollin PE. Lassa Fever in Travelers from West Africa, 1969\u20132016. Emerg Infect Dis. 2019;25(2):245\u20138.","journal-title":"Emerg Infect Dis"},{"issue":"15","key":"13875_CR18","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1056\/NEJM197710132971504","volume":"297","author":"RM Zweighaft","year":"1977","unstructured":"Zweighaft RM, Fraser DW, Hattwick MAW, Winkler WG, Jordan WC, Alter M, et al. Lassa Fever: Response to an Imported Case. N Engl J Med. 1977;297(15):803\u20137.","journal-title":"N Engl J Med"},{"issue":"16","key":"13875_CR19","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1056\/NEJM199010183231607","volume":"323","author":"GP Holmes","year":"1990","unstructured":"Holmes GP, McCormick JB, Trock SC, Chase RA, Lewis SM, Mason CA, et al. Lassa Fever in the United States. N Engl J Med. 1990;323(16):1120\u20133.","journal-title":"N Engl J Med"},{"issue":"38","key":"13875_CR20","first-page":"894","volume":"53","author":"Centers for Disease Control and Prevention (CDC)","year":"2004","unstructured":"Centers for Disease Control and Prevention (CDC). Imported Lassa fever\u2013New Jersey, 2004. MMWR Morb Mortal Wkly Rep. 2004;53(38):894\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"13875_CR21","doi-asserted-by":"crossref","unstructured":"Amorosa V, MacNeil A, McConnell R, Patel A, Dillon KE, Hamilton K, et al. Imported Lassa fever, Pennsylvania, USA, 2010. Emerg Infect Dis. 2010;16(10):1598\u2013600.","DOI":"10.3201\/eid1610.100774"},{"issue":"4","key":"13875_CR22","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.4269\/ajtmh.17-0316","volume":"99","author":"PA Kulkarni","year":"2018","unstructured":"Kulkarni PA, Chew D, Youssef-Bessler M, Hamdi HA, Montoya LA, Cervantes KB, et al. Case Report: Imported Case of Lassa Fever \u2014 New Jersey, May 2015. Am J Trop Med Hyg. 2018;99(4):1062\u20135.","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"13875_CR23","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1093\/infdis\/jix201","volume":"215","author":"AK McElroy","year":"2017","unstructured":"McElroy AK, Akondy RS, Harmon JR, Ellebedy AH, Cannon D, Klena JD, et al. A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses. J Infect Dis. 2017;215(12):1862\u201372.","journal-title":"J Infect Dis"},{"issue":"3","key":"13875_CR24","doi-asserted-by":"publisher","first-page":"108405","DOI":"10.5501\/wjv.v14.i3.108405","volume":"14","author":"PK Uppala","year":"2025","unstructured":"Uppala PK, Karanam SK, Kandra NV, Edhi S. Lassa fever: A comprehensive review of virology, clinical management, and global health implications. World J Virol. 2025;14(3):108405.","journal-title":"World J Virol"},{"issue":"7426","key":"13875_CR25","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1136\/bmj.327.7426.1271","volume":"327","author":"JK Richmond","year":"2003","unstructured":"Richmond JK. Lassa fever: epidemiology, clinical features, and social consequences. BMJ. 2003;327(7426):1271\u20135.","journal-title":"BMJ"},{"issue":"10","key":"13875_CR26","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3390\/ijerph22101504","volume":"22","author":"AP Okwuraiwe","year":"2025","unstructured":"Okwuraiwe AP, Onyeaghala CA, Ozoude OT, Suleiman MO, Abdu-Aguye SN, Ezekwelu NJ, et al. Clinical Outcomes of Severe Lassa Fever in West Africa: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2025;22(10):1504.","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"13875_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41579-022-00789-8","volume":"21","author":"RF Garry","year":"2023","unstructured":"Garry RF. Lassa fever \u2014 the road ahead. Nat Rev Microbiol. 2023;21(2):87\u201396.","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"13875_CR28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/0035-9203(86)90147-1","volume":"80","author":"PA Webb","year":"1986","unstructured":"Webb PA, McCormick JB, King IJ, Bosman I, Johnson KM, Elliott LH, et al. Lassa fever in children in Sierra Leone, West Africa. Trans R Soc Trop Med Hyg. 1986;80(4):577\u201382.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"13875_CR29","doi-asserted-by":"publisher","first-page":"408","DOI":"10.4269\/ajtmh.1987.36.408","volume":"36","author":"MH Monson","year":"1987","unstructured":"Monson MH, Cole AK, Frame JD, Serwint JR, Alexander S, Jahrling PB. Pediatric Lassa Fever: A Review of 33 Liberian Cases. Am J Trop Med Hyg. 1987;36(2):408\u201315.","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"13875_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/jpids\/piae083","volume":"13","author":"A Duvignaud","year":"2024","unstructured":"Duvignaud A, Etafo IC, Jaspard M, Salau Q, Serra B, Kareem AJ, et al. Presentation and Outcomes of Lassa Fever in Children in Nigeria: A Prospective Cohort Study (LASCOPE). J Pediatr Infect Dis Soc. 2024;13(10):513\u201322.","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"6648","key":"13875_CR31","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1136\/bmj.297.6648.584","volume":"297","author":"ME Price","year":"1988","unstructured":"Price ME, Fisher-Hoch SP, Craven RB, McCormick JB. A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. BMJ. 1988;297(6648):584\u20137.","journal-title":"BMJ"},{"issue":"8","key":"13875_CR32","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.3201\/eid2508.181299","volume":"25","author":"S Okogbenin","year":"2019","unstructured":"Okogbenin S, Okoeguale J, Akpede G, Colubri A, Barnes KG, Mehta S, et al. Retrospective Cohort Study of Lassa Fever in Pregnancy, Southern Nigeria. Emerg Infect Dis. 2019;25(8):1494\u2013500.","journal-title":"Emerg Infect Dis"},{"key":"13875_CR33","doi-asserted-by":"crossref","unstructured":"Cummins D, McCormick JB, Bennett D, Samba JA, Farrar B, Machin SJ, et al. Acute sensorineural deafness in Lassa fever. JAMA. 1990;264(16):2093\u20136.","DOI":"10.1001\/jama.1990.03450160063030"},{"issue":"2","key":"13875_CR34","doi-asserted-by":"publisher","first-page":"e0006187","DOI":"10.1371\/journal.pntd.0006187","volume":"12","author":"EJ Mateer","year":"2018","unstructured":"Mateer EJ, Huang C, Shehu NY, Paessler S. Lassa fever\u2013induced sensorineural hearing loss: A neglected public health and social burden. PLoS Negl Trop Dis. 2018;12(2):e0006187.","journal-title":"PLoS Negl Trop Dis"},{"key":"13875_CR35","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.coviro.2019.08.002","volume":"37","author":"AN Happi","year":"2019","unstructured":"Happi AN, Happi CT, Schoepp RJ. Lassa fever diagnostics: past, present, and future. Curr Opin Virol. 2019;37:132\u20138.","journal-title":"Curr Opin Virol"},{"issue":"12","key":"13875_CR36","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1128\/jcm.32.12.2898-2903.1994","volume":"32","author":"AH Demby","year":"1994","unstructured":"Demby AH, Chamberlain J, Brown DW, Clegg CS. Early diagnosis of Lassa fever by reverse transcription-PCR. J Clin Microbiol. 1994;32(12):2898\u2013903.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"13875_CR37","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1128\/JCM.00170-17","volume":"55","author":"V Raabe","year":"2017","unstructured":"Raabe V, Koehler J. Laboratory Diagnosis of Lassa Fever. J Clin Microbiol. 2017;55(6):1629\u201337.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"13875_CR38","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1186\/s12879-019-4242-6","volume":"19","author":"NF Takah","year":"2019","unstructured":"Takah NF, Brangel P, Shrestha P, Peeling R. Sensitivity and specificity of diagnostic tests for Lassa fever: a systematic review. BMC Infect Dis. 2019;19(1):647.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"13875_CR39","doi-asserted-by":"publisher","first-page":"e469","DOI":"10.1016\/S2214-109X(20)30518-0","volume":"9","author":"A Duvignaud","year":"2021","unstructured":"Duvignaud A, Jaspard M, Etafo IC, Gabillard D, Serra B, Abejegah C, et al. Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study. Lancet Glob Health. 2021;9(4):e469\u201378.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"13875_CR40","doi-asserted-by":"publisher","first-page":"6545","DOI":"10.1038\/s41598-023-33187-y","volume":"13","author":"CL Ochu","year":"2023","unstructured":"Ochu CL, Ntoimo L, Onoh I, Okonofua F, Meremikwu M, Mba S, et al. Predictors of Lassa fever diagnosis in suspected cases reporting to health facilities in Nigeria. Sci Rep. 2023;13(1):6545.","journal-title":"Sci Rep"},{"issue":"1","key":"13875_CR41","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/1743-422X-8-478","volume":"8","author":"LM Branco","year":"2011","unstructured":"Branco LM, Grove JN, Boisen ML, Shaffer JG, Goba A, Fullah M, et al. Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection. Virol J. 2011;8(1):478.","journal-title":"Virol J"},{"issue":"3","key":"13875_CR42","doi-asserted-by":"publisher","first-page":"e0214284","DOI":"10.1371\/journal.pone.0214284","volume":"14","author":"JG Shaffer","year":"2019","unstructured":"Shaffer JG, Schieffelin JS, Gbakie M, Alhasan F, Roberts NB, Goba A, et al. A medical records and data capture and management system for Lassa fever in Sierra Leone: Approach, implementation, and challenges. PLoS ONE. 2019;14(3):e0214284.","journal-title":"PLoS ONE"},{"issue":"4","key":"13875_CR43","doi-asserted-by":"publisher","first-page":"taaa035","DOI":"10.1093\/jtm\/taaa035","volume":"27","author":"T Wolf","year":"2020","unstructured":"Wolf T, Ellwanger R, Goetsch U, Wetzstein N, Gottschalk R. Fifty years of imported Lassa fever: a systematic review of primary and secondary cases. J Travel Med. 2020;27(4):taaa035.","journal-title":"J Travel Med"},{"key":"13875_CR44","doi-asserted-by":"publisher","first-page":"256","DOI":"10.11604\/pamj.2022.42.256.35838","volume":"42","author":"U Sesay","year":"2022","unstructured":"Sesay U, Hakizimana L, Elduma A, Henderson A, Gebru GN. Late diagnosis of Lassa fever outbreak in endemic areas lead to high mortality, Kenema District, Sierra Leone, February - March 2019. Pan Afr Med J. 2022;42:256.","journal-title":"Pan Afr Med J"},{"issue":"9","key":"13875_CR45","doi-asserted-by":"publisher","first-page":"e0009788","DOI":"10.1371\/journal.pntd.0009788","volume":"15","author":"L Merson","year":"2021","unstructured":"Merson L, Bourner J, Jalloh S, Erber A, Salam AP, Flahault A, et al. Clinical characterization of Lassa fever: A systematic review of clinical reports and research to inform clinical trial design. PLoS Negl Trop Dis. 2021;15(9):e0009788.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"13875_CR46","doi-asserted-by":"publisher","first-page":"e2748","DOI":"10.1371\/journal.pntd.0002748","volume":"8","author":"JG Shaffer","year":"2014","unstructured":"Shaffer JG, Grant DS, Schieffelin JS, Boisen ML, Goba A, Hartnett JN, et al. Lassa Fever in Post-Conflict Sierra Leone. PLoS Negl Trop Dis. 2014;8(3):e2748.","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"13875_CR47","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S1473-3099(24)00184-1","volume":"24","author":"J Elsinga","year":"2024","unstructured":"Elsinga J, Sunyoto T, di Stefano L, Giorgetti PF, Kyi HA, Burzio C, et al. Field evaluation of validity and feasibility of Pan-Lassa rapid diagnostic test for Lassa fever in Abakaliki, Nigeria: a prospective diagnostic accuracy study. Lancet Infect Dis. 2024;24(9):1037\u201344.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"13875_CR48","doi-asserted-by":"publisher","first-page":"8724","DOI":"10.1038\/s41598-020-65736-0","volume":"10","author":"ML Boisen","year":"2020","unstructured":"Boisen ML, Uyigue E, Aiyepada J, Siddle KJ, Oestereich L, Nelson DKS, et al. Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak. Sci Rep. 2020;10(1):8724.","journal-title":"Sci Rep"},{"issue":"1","key":"13875_CR49","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12985-020-01459-y","volume":"17","author":"TV Gale","year":"2020","unstructured":"Gale TV, Schieffelin JS, Branco LM, Garry RF, Grant DS. Elevated l-threonine is a biomarker for Lassa fever and Ebola. Virol J. 2020;17(1):188.","journal-title":"Virol J"},{"key":"13875_CR50","doi-asserted-by":"crossref","unstructured":"Collins B, Rabiger DS, Gurling M, Helm JR, Smith W, Belgique P, et al. 2072. Clinical evaluation of the biofire global fever special pathogens panel. Open Forum Infect Dis. 2023;10(Supplement_2).","DOI":"10.1093\/ofid\/ofad500.142"},{"issue":"1","key":"13875_CR51","doi-asserted-by":"publisher","first-page":"20640","DOI":"10.1038\/s41598-025-07071-w","volume":"15","author":"T Wei","year":"2025","unstructured":"Wei T, Yan Y, Niu M, Dong X, Li H, Sun Y, et al. A rapid LASV detection method based on CRISPR-Cas13a and recombinase aided amplification with special lateral-flow test strips. Sci Rep. 2025;15(1):20640.","journal-title":"Sci Rep"},{"issue":"3","key":"13875_CR52","first-page":"279","volume":"38","author":"Y Feng","year":"2025","unstructured":"Feng Y, Li W, Jiang M, Zhong H, Wu W, Tian L, et al. Laboratory Diagnosis and Molecular Epidemiological Characterization of the First Imported Case of Lassa Fever in China. Biomed Environ Sci. 2025;38(3):279\u201389.","journal-title":"Biomed Environ Sci"},{"issue":"4","key":"13875_CR53","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.idc.2019.08.002","volume":"33","author":"DA Asogun","year":"2019","unstructured":"Asogun DA, G\u00fcnther S, Akpede GO, Ihekweazu C, Zumla A. Lassa Fever. Infect Dis Clin North Am. 2019;33(4):933\u201351.","journal-title":"Infect Dis Clin North Am"},{"issue":"1","key":"13875_CR54","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12941-021-00431-0","volume":"20","author":"LB Arruda","year":"2021","unstructured":"Arruda LB, Haider N, Olayemi A, Simons D, Ehichioya D, Yinka-Ogunleye A, et al. The niche of One Health approaches in Lassa fever surveillance and control. Ann Clin Microbiol Antimicrob. 2021;20(1):29.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"1","key":"13875_CR55","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13104-025-07218-y","volume":"18","author":"AO Yunus","year":"2025","unstructured":"Yunus AO, Olayiwola MO. Epidemiological analysis of Lassa fever control using novel mathematical modeling and a dual-dosage vaccination approach. BMC Res Notes. 2025;18(1):199.","journal-title":"BMC Res Notes"},{"issue":"10","key":"13875_CR56","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1086\/374853","volume":"36","author":"WH Haas","year":"2003","unstructured":"Haas WH, Breuer T, Pfaff G, Schmitz H, Kohler P, Asper M, et al. Imported Lassa Fever in Germany: Surveillance and Management of Contact Persons. Clin Infect Dis. 2003;36(10):1254\u20138.","journal-title":"Clin Infect Dis"},{"issue":"39","key":"13875_CR57","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2807\/1560-7917.ES.2017.22.39.16-00728","volume":"22","author":"L Ehlkes","year":"2017","unstructured":"Ehlkes L, George M, Samosny G, Burckhardt F, Vogt M, Bent S, et al. Management of a Lassa fever outbreak, Rhineland-Palatinate, Germany, 2016. Euro Surveill. 2017;22(39):16\u201300728.","journal-title":"Euro Surveill"},{"issue":"1","key":"13875_CR58","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJM198601023140104","volume":"314","author":"JB McCormick","year":"1986","unstructured":"McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med. 1986;314(1):20\u20136.","journal-title":"N Engl J Med"},{"key":"13875_CR59","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ijid.2019.07.015","volume":"87","author":"KA Eberhardt","year":"2019","unstructured":"Eberhardt KA, Mischlinger J, Jordan S, Groger M, G\u00fcnther S, Ramharter M. Ribavirin for the treatment of Lassa fever: A systematic review and meta-analysis. Int J Infect Dis. 2019;87:15\u201320.","journal-title":"Int J Infect Dis"},{"issue":"3","key":"13875_CR60","doi-asserted-by":"publisher","first-page":"e0010289","DOI":"10.1371\/journal.pntd.0010289","volume":"16","author":"AP Salam","year":"2022","unstructured":"Salam AP, Duvignaud A, Jaspard M, Malvy D, Carroll M, Tarning J, et al. Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing. PLoS Negl Trop Dis. 2022;16(3):e0010289.","journal-title":"PLoS Negl Trop Dis"},{"key":"13875_CR61","doi-asserted-by":"crossref","unstructured":"Cheng HY, French CE, Salam AP, Dawson S, McAleenan A, McGuinness LA, et al. Lack of evidence for ribavirin treatment of Lassa fever in systematic review of published and unpublished studies. Emerg Infect Dis. 2022;28(8):1559-68.","DOI":"10.3201\/eid2808.211787"},{"issue":"10","key":"13875_CR62","doi-asserted-by":"publisher","first-page":"ofae575","DOI":"10.1093\/ofid\/ofae575","volume":"11","author":"E Ogbaini-Emovon","year":"2024","unstructured":"Ogbaini-Emovon E, Akpede G, Okogbenin S, Osagiede E, Tobin E, Asogun D, et al. Virus Load Kinetics in Lassa Fever Patients Treated With Ribavirin: A Retrospective Cohort Study From Southern Nigeria. Open Forum Infect Dis. 2024;11(10):ofae575.","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"13875_CR63","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/trstmh\/traa011","volume":"114","author":"ND Kayem","year":"2020","unstructured":"Kayem ND, Benson C, Aye CYL, Barker S, Tome M, Kennedy S, et al. Lassa fever in pregnancy: a systematic review and meta-analysis. Trans R Soc Trop Med Hyg. 2020;114(5):385\u201396.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"7009","key":"13875_CR64","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1136\/bmj.311.7009.857","volume":"311","author":"SP Fisher-Hoch","year":"1995","unstructured":"Fisher-Hoch SP, Tomori O, Nasidi A, Perez-Oronoz GI, Fakile Y, Hutwagner L, et al. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ. 1995;311(7009):857\u20139.","journal-title":"BMJ"},{"issue":"1","key":"13875_CR65","doi-asserted-by":"publisher","first-page":"14775","DOI":"10.1038\/srep14775","volume":"5","author":"D Safronetz","year":"2015","unstructured":"Safronetz D, Rosenke K, Westover JB, Martellaro C, Okumura A, Furuta Y, et al. The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset. Sci Rep. 2015;5(1):14775.","journal-title":"Sci Rep"},{"issue":"9","key":"13875_CR66","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.3201\/eid2409.180233","volume":"24","author":"K Rosenke","year":"2018","unstructured":"Rosenke K, Feldmann H, Westover JB, Hanley PW, Martellaro C, Feldmann F, et al. Use of Favipiravir to Treat Lassa Virus Infection in Macaques. Emerg Infect Dis. 2018;24(9):1696\u20139.","journal-title":"Emerg Infect Dis"},{"issue":"668","key":"13875_CR67","doi-asserted-by":"publisher","first-page":"eabq0991","DOI":"10.1126\/scitranslmed.abq0991","volume":"14","author":"H Li","year":"2022","unstructured":"Li H, Buck T, Zandonatti M, Yin J, Moon-Walker A, Fang J, et al. A cocktail of protective antibodies subverts the dense glycan shield of Lassa virus. Sci Transl Med. 2022;14(668):eabq0991.","journal-title":"Sci Transl Med"},{"issue":"10","key":"13875_CR68","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/nm.4396","volume":"23","author":"CE Mire","year":"2017","unstructured":"Mire CE, Cross RW, Geisbert JB, Borisevich V, Agans KN, Deer DJ, et al. Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever. Nat Med. 2017;23(10):1146\u20139.","journal-title":"Nat Med"},{"issue":"34","key":"13875_CR69","doi-asserted-by":"publisher","first-page":"e2304876120","DOI":"10.1073\/pnas.2304876120","volume":"120","author":"RW Cross","year":"2023","unstructured":"Cross RW, Heinrich ML, Fenton KA, Borisevich V, Agans KN, Prasad AN, et al. A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus. Proc Natl Acad Sci U S A. 2023;120(34):e2304876120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"13875_CR70","doi-asserted-by":"publisher","first-page":"2301061","DOI":"10.1080\/22221751.2023.2301061","volume":"13","author":"C Woolsey","year":"2024","unstructured":"Woolsey C, Cross RW, Prasad AN, Agans KN, Borisevich V, Deer DJ, et al. Monoclonal antibody therapy demonstrates increased virulence of a lineage VII strain of Lassa virus in nonhuman primates. Emerg Microbes Infect. 2024;13(1):2301061.","journal-title":"Emerg Microbes Infect"},{"issue":"10","key":"13875_CR71","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.3201\/eid2810.220625","volume":"28","author":"S Okogbenin","year":"2022","unstructured":"Okogbenin S, Erameh C, Okoeguale J, Edeawe O, Ekuaze E, Iraoyah K, et al. Two Cases of Lassa Fever Successfully Treated with Ribavirin and Adjunct Dexamethasone for Concomitant Infections. Emerg Infect Dis. 2022;28(10):2060\u20133.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"13875_CR72","doi-asserted-by":"publisher","first-page":"246","DOI":"10.4103\/0300-1652.188362","volume":"57","author":"SE Isa","year":"2016","unstructured":"Isa SE, Okwute A, Iraoyah KO, Nathan SY, Simji GS, Okolo MO, et al. Postexposure prophylaxis for Lassa fever: Experience from a recent outbreak in Nigeria. Niger Med J. 2016;57(4):246\u201350.","journal-title":"Niger Med J"},{"issue":"6","key":"13875_CR73","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/tmi.13876","volume":"28","author":"G Sulis","year":"2023","unstructured":"Sulis G, Peebles A, Basta NE. Lassa fever vaccine candidates: A scoping review of vaccine clinical trials. Trop Med Int Health. 2023;28(6):420\u201331.","journal-title":"Trop Med Int Health"},{"issue":"18","key":"13875_CR74","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1056\/NEJMoa2501073","volume":"393","author":"E Malkin","year":"2025","unstructured":"Malkin E, Zaric M, Kieh M, Baden LR, Fitz-Patrick D, Marini A, et al. Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate. N Engl J Med. 2025;393(18):1807\u201318.","journal-title":"N Engl J Med"},{"issue":"3","key":"13875_CR75","doi-asserted-by":"publisher","first-page":"111094","DOI":"10.1016\/j.celrep.2022.111094","volume":"40","author":"RW Cross","year":"2022","unstructured":"Cross RW, Woolsey C, Prasad AN, Borisevich V, Agans KN, Deer DJ, et al. A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever. Cell Rep. 2022;40(3):111094.","journal-title":"Cell Rep"},{"key":"13875_CR76","unstructured":"Coalition for Epidemic Preparedness Innovations (CEPI). CEPI 2.0 and the 100 Days Mission. 2025."},{"issue":"10","key":"13875_CR77","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3390\/vaccines10101668","volume":"10","author":"H Murphy","year":"2022","unstructured":"Murphy H, Ly H. Understanding Immune Responses to Lassa Virus Infection and to Its Candidate Vaccines. Vaccines (Basel). 2022;10(10):1668.","journal-title":"Vaccines (Basel)"},{"issue":"8","key":"13875_CR78","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/j.vaccine.2024.02.044","volume":"42","author":"L Kabor\u00e9","year":"2024","unstructured":"Kabor\u00e9 L, Pecenka C, Hausdorff WP. Lassa fever vaccine use cases and demand: Perspectives from select West African experts. Vaccine. 2024;42(8):1873\u20137.","journal-title":"Vaccine"},{"key":"13875_CR79","unstructured":"HHS and USDA select agents and toxins. Select agents and toxins list. 2025."},{"key":"13875_CR80","unstructured":"Merck Manual. Merck Manual. CDC high-priority biological agents and toxins; 2025."},{"key":"13875_CR81","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40696-016-0018-3","volume":"2","author":"T Brosh-Nissimov","year":"2016","unstructured":"Brosh-Nissimov T. Lassa fever: another threat from West Africa. Disaster Mil Med. 2016;2:8.","journal-title":"Disaster Mil Med"},{"issue":"2","key":"13875_CR82","doi-asserted-by":"publisher","first-page":"173","DOI":"10.26444\/aaem\/201958","volume":"32","author":"N Cichon","year":"2025","unstructured":"Cichon N, Kurpesa N, Niemcewicz M, Podogrocki M, Bijak M. Bioterrorism potential of haemorrhagic fever viruses \u2013 occupational and environmental Implications of filoviruses and arenaviruses. Ann Agric Environ Med. 2025;32(2):173\u201384.","journal-title":"Ann Agric Environ Med"},{"key":"13875_CR83","unstructured":"World Health Organization. WHO R&D Blueprint for Epidemics. Targeting research on diseases of greatest epidemic and pandemic threat; 2025."},{"key":"13875_CR84","unstructured":"Nigeria Centre for Disease Control. Viral haemorrhagic fevers preparedness and response plan. 2017."},{"issue":"5","key":"13875_CR85","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3201\/eid1205.050052","volume":"12","author":"AM Macher","year":"2006","unstructured":"Macher AM, Wolfe MS. Historical Lassa fever reports and 30-year clinical update. Emerg Infect Dis. 2006;12(5):835\u20137.","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"13875_CR86","first-page":"627","volume":"117","author":"A Glover","year":"2023","unstructured":"Glover A, Perryman S, Turtle L, Turtle CJ. Lassa fever cases suffer from severe underreporting based on reported fatalities. Trans R Soc Trop Med Hyg. 2023;117(9):627\u201330.","journal-title":"Trans R Soc Trop Med Hyg"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13875-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13875-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13875-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:04:20Z","timestamp":1789520660000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13875-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13875"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13875-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article is a narrative review of previously published literature and does not contain any studies involving human participants or animals performed by the authors; therefore, ethics approval and consent were not required.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1660"}}